{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:26:40Z","timestamp":1778538400999,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100010892","name":"Department of Science and Technology","doi-asserted-by":"crossref","award":["SR\/FST\/LS- I\/2018\/131"],"award-info":[{"award-number":["SR\/FST\/LS- I\/2018\/131"]}],"id":[{"id":"10.13039\/501100010892","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11030-020-10159-2","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T16:03:44Z","timestamp":1609776224000},"page":"1795-1809","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Identification of novel inhibitors of angiotensin-converting enzyme 2 (ACE-2) receptor from Urtica dioica to combat coronavirus disease 2019 (COVID-19)"],"prefix":"10.1007","volume":"25","author":[{"given":"Shobha","family":"Upreti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyoti Sankar","family":"Prusty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satish Chandra","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awanish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0154-2421","authenticated-orcid":false,"given":"Mukesh","family":"Samant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"issue":"6","key":"10159_CR1","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","volume":"24","author":"S Su","year":"2016","unstructured":"Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, Liu W, Bi Y, Gao GF (2016) Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol 24(6):490\u2013502","journal-title":"Trends Microbiol"},{"key":"10159_CR2","doi-asserted-by":"crossref","unstructured":"Omar S, Bouziane I, Bouslama Z, Djemel A (2020) In-silico identification of potent inhibitors of COVID-19 main protease (Mpro) and Angiotensin Converting Enzyme 2 (ACE2) from Natural Products: Quercetin, Hispidulin, and Cirsimaritin Exhibited Better Potential Inhibition than Hydroxy-Chloroquine Against COVID-19 Main Protease Active Site and ACE2","DOI":"10.26434\/chemrxiv.12181404"},{"key":"10159_CR3","doi-asserted-by":"crossref","unstructured":"McIntosh K, Perlman S (2015) Coronaviruses, including severe acute respiratory syndrome (SARS) and middle east respiratory syndrome (MERS). Mandell Douglas Bennett\u2019s Princ Pract Infect Dis 1928","DOI":"10.1016\/B978-1-4557-4801-3.00157-0"},{"issue":"6","key":"10159_CR4","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/jmv.25726","volume":"92","author":"Z Liu","year":"2020","unstructured":"Liu Z, Xiao X, Wei X, Li J, Yang J, Tan H, Zhu J, Zhang Q, Wu J, Liu L (2020) Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol 92(6):595\u2013601","journal-title":"J Med Virol"},{"key":"10159_CR5","doi-asserted-by":"crossref","unstructured":"Robson B (2020) Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus. In: Computers in biology and medicine, pp 103670","DOI":"10.1016\/j.compbiomed.2020.103670"},{"issue":"3","key":"10159_CR6","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1128\/JVI.02935-13","volume":"88","author":"VS Raj","year":"2014","unstructured":"Raj VS, Smits SL, Provacia LB, van den Brand JMA, Wiersma L, Ouwendijk WJD, Bestebroer TM, Spronken MI, van Amerongen G, Rottier PJM (2014) Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus. J Virol 88(3):1834\u20131838","journal-title":"J Virol"},{"key":"10159_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.virusres.2014.10.007","volume":"194","author":"S Xia","year":"2014","unstructured":"Xia S, Liu Q, Wang Q, Sun Z, Su S, Du L, Ying T, Lu L, Jiang S (2014) Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein. Virus Res 194:200\u2013210","journal-title":"Virus Res"},{"key":"10159_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.virusres.2014.07.024","volume":"194","author":"ML De Diego","year":"2014","unstructured":"De Diego ML, Nieto-Torres JL, Jimenez-Guarde\u00f1o JM, Regla-Nava JA, Casta\u00f1o-Rodriguez C, Fernandez-Delgado R, Usera F, Enjuanes L (2014) Coronavirus virulence genes with main focus on SARS-CoV envelope gene. Virus Res 194:124\u2013137","journal-title":"Virus Res"},{"key":"10159_CR9","doi-asserted-by":"publisher","first-page":"117956","DOI":"10.1016\/j.lfs.2020.117956","volume":"256","author":"SC Pandey","year":"2020","unstructured":"Pandey SC, Pande V, Sati D, Upreti S, Samant M (2020) Vaccination strategies to combat novel corona virus SARS-CoV-2. Life Sci 256:117956","journal-title":"Life Sci"},{"key":"10159_CR10","first-page":"117956","volume":"290","author":"P Khare","year":"2020","unstructured":"Khare P, Sahu U, Pandey SC, Samant M (2020) Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection. Virus Res 290:1\u20138.","journal-title":"Life Sci"},{"key":"10159_CR11","doi-asserted-by":"crossref","unstructured":"Koulgi S, Jani V, Uppuladinne M, Sonavane U, Nath AK, Darbari H, Joshi R (2020) Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CLpro). J Biomol Struct Dyn 1\u201321","DOI":"10.1080\/07391102.2020.1792344"},{"key":"10159_CR12","doi-asserted-by":"crossref","unstructured":"Patel CN, Kumar SP, Pandya HA, Rawal RM (2020) Identification of potential inhibitors of coronavirus hemagglutinin-esterase using molecular docking, molecular dynamics simulation and binding free energy calculation. Mol Divers 1\u201313","DOI":"10.1007\/s11030-020-10135-w"},{"issue":"4","key":"10159_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4103\/0973-8258.142669","volume":"8","author":"BC Joshi","year":"2014","unstructured":"Joshi BC, Mukhija M, Kalia AN (2014) Pharmacognostical review of Urtica dioica L. Int J Green Pharm 8(4):201\u2013209","journal-title":"Int J Green Pharm"},{"issue":"4","key":"10159_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s13659-020-00250-4","volume":"10","author":"IE Orhan","year":"2020","unstructured":"Orhan IE, Senol Deniz FS (2020) Natural products as potential leads against coronaviruses: could they be encouraging structural models against SARS-CoV-2? Nat Prod Bioprospect 10(4):171\u2013186","journal-title":"Nat Prod Bioprospect"},{"issue":"7","key":"10159_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JVI.00127-20","volume":"94","author":"Y Wan","year":"2020","unstructured":"Wan Y, Shang J, Graham R, Baric RS, Li F (2020) Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol 94(7):1\u20139.","journal-title":"J Virol"},{"issue":"21","key":"10159_CR16","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1007\/s00018-004-4240-7","volume":"61","author":"FJ Warner","year":"2004","unstructured":"Warner FJ, Smith AI, Hooper NM, Turner AJ (2004) Angiotensin-converting enzyme-2: a molecular and cellular perspective. Cell Mol Life Sci 61(21):2704\u20132713","journal-title":"Cell Mol Life Sci"},{"issue":"46","key":"10159_CR17","first-page":"5714","volume":"6","author":"J Asgarpanah","year":"2012","unstructured":"Asgarpanah J, Mohajerani R (2012) Phytochemistry and pharmacologic properties of Urtica dioica L. J Med Plants Res 6(46):5714\u20135719","journal-title":"J Med Plants Res"},{"issue":"1","key":"10159_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.antiviral.2011.02.003","volume":"90","author":"Y Kumaki","year":"2011","unstructured":"Kumaki Y, Wandersee MK, Smith AJ, Zhou Y, Simmons G, Nelson NM, Bailey KW, Vest ZG, Li JKK, Chan PK-S (2011) Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB\/c mouse model by stinging nettle lectin, Urtica dioica agglutinin. Antivir Res 90(1):22\u201332","journal-title":"Antivir Res"},{"key":"10159_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","volume":"1263","author":"S Dallakyan","year":"2015","unstructured":"Dallakyan S, Olson AJ (2015) Small-molecule library screening by docking with PyRx. Methods Mol Biol 1263:243\u2013250","journal-title":"Methods Mol Biol"},{"issue":"2","key":"10159_CR20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461","journal-title":"J Comput Chem"},{"issue":"2","key":"10159_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/scipharm88020029","volume":"88","author":"NF Al-Tannak","year":"2020","unstructured":"Al-Tannak NF, Novotny L, Alhunayan A (2020) Remdesivir-bringing hope for COVID-19 treatment. Sci Pharm 88(2):29","journal-title":"Sci Pharm"},{"issue":"1","key":"10159_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2478\/jtim-2020-0003","volume":"8","author":"M Liu","year":"2020","unstructured":"Liu M, Wang T, Zhou Y, Zhao Y, Zhang Y, Li J (2020) Potential Role of ACE2 in Coronavirus Disease 2019 (COVID-19) Prevention and Management. J Transl Int Med 8(1):9\u201319","journal-title":"J Transl Int Med"},{"key":"10159_CR23","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/bs.aivir.2019.08.002","volume":"105","author":"MA Tortorici","year":"2019","unstructured":"Tortorici MA, Veesler D (2019) Structural insights into coronavirus entry. Adv Virus Res 105:93\u2013116","journal-title":"Adv Virus Res"},{"issue":"1","key":"10159_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13063-017-2427-0","volume":"19","author":"YM Arabi","year":"2018","unstructured":"Arabi YM, Alothman A, Balkhy HH, Al-Dawood A, AlJohani S, Al Harbi S, Kojan S, Al Jeraisy M, Deeb AM, Assiri AM, Al-Hameed F, AlSaedi A, Mandourah Y, Almekhlafi GA, Sherbeeni NM, Elzein FE, Memon J, Taha Y, Almotairi A, Maghrabi KA, Qushmaq I, Al Bshabshe A, Kharaba A, Shalhoub S, Jose J, Fowler RA, Hayden FG, Hussein MA (2018) Treatment of middle east respiratory syndrome with a combination of lopinavir-ritonavir and interferon-beta1b (MIRACLE trial): study protocol for a randomized controlled trial. Trials 19(1):81","journal-title":"Trials"},{"issue":"3 suppl","key":"10159_CR25","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.21873\/invivo.11949","volume":"34","author":"S Bimonte","year":"2020","unstructured":"Bimonte S, Crispo A, Amore A, Celentano E, Cuomo A, Cascella M (2020) Potential antiviral drugs for SARS-Cov-2 treatment: preclinical findings and ongoing clinical research. Vivo 34(3 suppl):1597\u20131602","journal-title":"Vivo"},{"issue":"3s","key":"10159_CR26","doi-asserted-by":"publisher","first-page":"1075S","DOI":"10.1093\/jn\/131.3.1075S","volume":"131","author":"E Kyo","year":"2001","unstructured":"Kyo E, Uda N, Kasuga S, Itakura Y (2001) Immunomodulatory effects of aged garlic extract. J Nutr 131(3s):1075S\u20131079S","journal-title":"J Nutr"},{"issue":"10","key":"10159_CR27","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1080\/10408398.2011.633249","volume":"54","author":"MT Sultan","year":"2014","unstructured":"Sultan MT, Butt MS, Qayyum MM, Suleria HA (2014) Immunity: plants as effective mediators. Crit Rev Food Sci Nutr 54(10):1298\u20131308","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"20","key":"10159_CR28","doi-asserted-by":"publisher","first-page":"17132","DOI":"10.1074\/jbc.M006723200","volume":"276","author":"H Zhang","year":"2001","unstructured":"Zhang H, Wada J, Hida K, Tsuchiyama Y, Hiragushi K, Shikata K, Wang H, Lin S, Kanwar YS, Makino H (2001) Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys. J Biol Chem 276(20):17132\u201317139","journal-title":"J Biol Chem"},{"issue":"8","key":"10159_CR29","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.3390\/ijms21083003","volume":"21","author":"D D\u2019Ardes","year":"2020","unstructured":"D\u2019Ardes D, Boccatonda A, Rossi I, Guagnano MT, Santilli F, Cipollone F, Bucci M (2020) COVID-19 and RAS: unravelling an unclear relationship. Int J Mol Sci 21(8):3003","journal-title":"Int J Mol Sci"},{"key":"10159_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.yjmcc.2020.04.031","volume":"144","author":"D Gro\u00dfS","year":"2020","unstructured":"Gro\u00dfS, Jahn C, Cushman S, B\u00e4r C, Thum T (2020) SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: from basic science to clinical implications. J Mol Cell Cardiol 144:47\u201353.","journal-title":"J Mol Cell Cardiol"},{"key":"10159_CR31","doi-asserted-by":"publisher","unstructured":"Zhang J-J, Shen X, Yan Y-M, Yan W, Cheng Y-X (2020) Discovery of anti-SARS-CoV-2 agents from commercially available flavor via docking screening. https:\/\/doi.org\/10.31219\/osf.io\/vjch2","DOI":"10.31219\/osf.io\/vjch2"},{"issue":"11","key":"10159_CR32","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/nrd941","volume":"1","author":"J Bajorath","year":"2002","unstructured":"Bajorath J (2002) Integration of virtual and high-throughput screening. Nat Rev Drug Discov 1(11):882\u2013894","journal-title":"Nat Rev Drug Discov"},{"issue":"15","key":"10159_CR33","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1002\/1521-3773(20020802)41:15<2644::AID-ANIE2644>3.0.CO;2-O","volume":"41","author":"H Gohlke","year":"2002","unstructured":"Gohlke H, Klebe G (2002) Approaches to the description and prediction of the binding affinity of small-molecule ligands to macromolecular receptors. Angew Chem Int Ed Engl 41(15):2644\u20132676","journal-title":"Angew Chem Int Ed Engl"},{"issue":"7","key":"10159_CR34","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2174\/1381612013397861","volume":"7","author":"T Langer","year":"2001","unstructured":"Langer T, Hoffmann RD (2001) Virtual screening: an effective tool for lead structure discovery? Curr Pharm Des 7(7):509\u2013527","journal-title":"Curr Pharm Des"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-020-10159-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-020-10159-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-020-10159-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T17:04:37Z","timestamp":1697475877000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-020-10159-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10159"],"URL":"https:\/\/doi.org\/10.1007\/s11030-020-10159-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-86926\/v1","asserted-by":"object"}]},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"assertion":[{"value":"27 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}